GlobeNews Wire

2025 CCM Benchmark Report Highlights the Importance of Contracting Maturity Amid Global Uncertainty

~AI Adoption Emerges as a Key Catalyst for Commercial Resilience~ LEHI, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Sirion, the…

5 months ago

CJ Biomaterials signs partnership with BIQ Materials to produce artificial turf infill made with PHACT PHA, a certified biodegradable biopolymer, for the European market

CJ Biomaterials signed an agreement with BIQ Materials, a Swedish biomaterials compounding company, to accelerate the commercialization of PHACT™ PHA-based…

5 months ago

Outset Medical to Present at the 2025 Stifel Healthcare Conference

November 05, 2025 09:00 ET  | Source: Outset Medical, Inc. SAN JOSE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Outset…

5 months ago

Solana Company (NASDAQ: HSDT) Releases Investor Update

November 05, 2025 09:00 ET  | Source: Solana Company NEWTOWN, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ:…

5 months ago

Global-e to Announce Financial Results for the Third Quarter 2025 on November 19, 2025

November 04, 2025 17:36 ET  | Source: Global-e Online Ltd PETAH-TIKVA, Israel, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Global-e Online…

5 months ago

Urgently Announces Third Quarter 2025 Earnings Release Date and Conference Call

November 04, 2025 17:21 ET  | Source: Urgent.ly Inc. ASHBURN, Va., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Urgent.ly Inc. (Nasdaq:…

5 months ago

Constellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the Third Quarter Ended September 30, 2025

November 04, 2025 17:06 ET  | Source: Topicus.com Inc. TORONTO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) in…

5 months ago

Fueling Discovery: Misophonia Research Fund Launches New Team Science Award, Expands 2026 Funding Opportunities, and Announces Latest Grantee Cohort

CHICAGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The Misophonia Research Fund (MRF), an initiative of the REAM Foundation, announces a…

5 months ago

Aardvark Therapeutics Presents Data Supporting its Metabolic Obesity Pipeline Programs at ObesityWeek 2025

New preclinical results demonstrate the potential of ARD-201 in enhanced glucose control, along with preservation of lean mass, underscoring its…

5 months ago

Rivus Pharmaceuticals Presents Preclinical Data for Controlled Metabolic Accelerator (CMA) Pipeline Showing Fat-Selective, Muscle-Preserving Weight Loss in Obesity at ObesityWeek

CHARLOTTESVILLE, Va. and SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company…

5 months ago